VSV-hIFNbeta-NIS (University of Tennessee)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVSV-hIFNbeta-NIS (University of Tennessee)
Drug Alias NameBOEC-VSV-IFN-betarecombinant vesicular stomatitis virus (cancer)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionInterferon beta modulators
TargetsInterferon beta
Therapy Area/IndicationsEndometrial NeoplasmsMultiple MyelomaLymphoma, T-Cell +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Tennessee
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsEndometrial NeoplasmsMultiple MyelomaLymphoma, T-Cell +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A